INDIANAPOLIS – To help cancer patients overcome the effects of chemotherapy, one IU IU Simon Cancer Centerresearcher has set out to create a new drug.
With a $2.9 million grant from the National Cancer Institute, Mark Kelley of the IU Simon Cancer Center, plans to develop the drug that will help patients beat Neuropathy.
The condition occurs during chemotherapy treatment and causes a tingling and burning sensation in patient’s hands and feet.
Learn more about the drug research in the video player.
